Plasmablastic lymphomas with MYC/IgH rearrangement: Report of three cases and review of the literature

American Journal of Clinical Pathology

Volumn 132, Issue 4, 2009, Pages 597-605

  Bogusz, Agata M ^a   Seegmiller, Adam C ^a   Garcia, Rolando ^a   Shang, Ping ^a   Ashfaq, Raheela ^a   Chen, Weina ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

HIV AIDS related lymphomas; MYC rearrangement; Plasmablastic lymphoma; t(8; 14)

Indexed keywords

BLEOMYCIN; CD38 ANTIGEN; CELL NUCLEUS ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; VINCRISTINE; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; ANTIGEN EXPRESSION; ANUS; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOBLASTIC LYMPHOMA; IMMUNOPHENOTYPING; MALE; MEDIASTINUM; ONCOGENE MYC; PRIORITY JOURNAL; CASE REPORT; FATALITY; GENETICS; PATHOLOGY; REVIEW;

ADULT; FATAL OUTCOME; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENES, MYC; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC; MALE;

EID: 70349569223     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPFUR1BK0UODTS     Document Type: Article

References (26)

1. Carbone A. AIDS-related non-Hodgkin's lymphomas: from pathology and molecular pathogenesis to treatment. Hum Pathol. 2002;33:392-404. (Pubitemid 34627589)
2. Stein H, Harris NL, Campo E. Plasmablastic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008:256-257.
3. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89:1413-1420. (Pubitemid 27080006)
4. Rafaniello Raviele P, Pruneri G, Maiorano E. Plasmablastic lymphoma: a review. Oral Dis. 2009;15:38-45.
5. Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28:736-747. (Pubitemid 38685887)
6. Vega F, Chang CC, Medeiros LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol. 2005;18:806-815. (Pubitemid 40780514)
7. Dong HY, Scadden DT, de Leval L, et al. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol. 2005;29:1633-1641.
8. Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol. 2008;83:804-809.
9. Arbiser JL, Mann KP, Losken EM, et al. Presence of p16 hypermethylation and Epstein-Barr virus infection in transplant-associated hematolymphoid neoplasm of the skin. J Am Acad Dermatol. 2006;55:794-798.
10. Hassan A, Kreisel F, Gardner L, et al. Plasmablastic lymphoma of head and neck: report of two new cases and correlation with c-myc and IgVH gene mutation status. Head Neck Pathol. 2007;1:150-155.
11. Chuah KL, Ng SB, Poon L, et al. Plasmablastic lymphoma affecting the lung and bone marrow with CD10 expression and t(8;14)(q24;q32) translocation [published online ahead of print May 28, 2008]. Int J Surg Pathol. 2009;17:163-166.
12. Dawson MA, Schwarer AP, McLean C, et al. AIDS-related plasmablastic lymphoma of the oral cavity associated with an IGH/MYC translocation: treatment with autologous stem-cell transplantation in a patient with severe haemophilia-A. Haematologica. 2007;92:e11-e12. doi:10.3324/haematol.10933.
13. Leoncini L, Raphael M, Stein H, et al. Burkitt lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008:262-264; vol 2.
14. Cogliatti SB, Novak U, Henz S, et al. Diagnosis of Burkitt lymphoma in due time: a practical approach. Br J Haematol. 2006;134:294-301. (Pubitemid 43990790)
15. Haralambieva E, Boerma EJ, van Imhoff GW, et al. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol. 2005;29:1086-1094. (Pubitemid 41045555)
16. McClure RF, Remstein ED, Macon WR, et al. Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. Am J Surg Pathol. 2005;29:1652-1660.
17. Rodig SJ, Vergilio JA, Shahsafaei A, et al. Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation. Am J Surg Pathol. 2008;32:113-122.
18. Kluin PM, Harris NL, Stein H, et al. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008:265-266.
19. Xu Y, McKenna RW, Doolittle JE, et al. The t(14;18) in diffuse large B-cell lymphoma: correlation with germinal center-associated markers and clinical features. Appl Immunohistochem Mol Morphol. 2005;13:116-123. (Pubitemid 40726846)
20. Chen W, Asplund SL, McKenna RW, et al. Characterization of incidentally identified minute clonal B-lymphocyte populations in peripheral blood and bone marrow. Am J Clin Pathol. 2004;122:588-595. (Pubitemid 39281257)
21. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317. (Pubitemid 38072572)
22. Boxer LM, Dang CV. Translocations involving c-myc and c-myc function. Oncogene. 2001;20:5595-5610.
23. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
24. Maleki A, Seegmiller AC, Uddin N, et al. Bright CD38 expression is an indicator of MYC rearrangement. Leuk Lymphoma. 2009;50:1054-1057.
25. Gaidano G, Cerri M, Capello D, et al. Molecular histogenesis of plasmablastic lymphoma of the oral cavity. Br J Haematol. 2002;119:622-628. (Pubitemid 35366199)
26. Avet-Loiseau H, Gerson F, Magrangeas F, et al. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors. Blood. 2001;98:3082-3086.